Faeth Therapeutics, Inc. (FTH) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$22.29M | +31.7% |
| 2024 | -$32.61M | +12.0% |
| 2023 | -$37.06M | +26.1% |
| 2022 | -$50.19M | -33.9% |
| 2021 | -$37.48M | -92.7% |
| 2020 | -$19.45M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$22.29M | +31.7% |
| 2024 | -$32.61M | +12.0% |
| 2023 | -$37.06M | +26.1% |
| 2022 | -$50.19M | -33.9% |
| 2021 | -$37.48M | -92.7% |
| 2020 | -$19.45M | — |